Scholars Central

Research articlePublished 2009

Evaluation of CEA and CA15.3 as circulating tumor markers in breast cancer patients in and around coimbatore

Authors: Sudha Sellappa, Shibily Prathyumnan, Sangeetha Raman

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Tumormarkers are biochemical signs of tumor existence and consist of cell surface antibodies, cytoplasm proteins, enzymes and hormones. The present study was performed to compare the level of CEA and CA15.3 as circulating tumor markers in breast cancer patients.Among 97 breast cancer subjects selected for the study, the levels of CEA and CA15.3 were observed in various stages of breast cancer. Mean level of CEA and CA15.3 were quantitatively determined by EIA. The finding revealed a statistical (p<0.05) elevation in the level of CEA in stage IV (100.00%) followed by stage III (53.84%) and stage II (33.33%). On comparison, the CA15.3 is considered to be the best to detect the early stages of breast cancer than CEA.Measuring the levels of CA15.3 and CEA canbe helpful for early diagnosis.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in BioTechnology: An Indian Journal.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBioTechnology: An Indian Journal
  • SubjectBiochemistry & Biotechnology
  • BylineArticles whose byline prints “Sudha Sellappa”
  • BylineArticles whose byline prints “Shibily Prathyumnan”
  • BylineArticles whose byline prints “Sangeetha Raman”